ARCHIVES

Core Grants Limit Formula Must Wait On Profiles

This article is from The Cancer Letter archive.

Vol. 04 No. 04 | January 27, 1978

Download PDF Visit The Full Archive

Related Articles

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014